About IVD Market in Europe
IVD tests help diagnose, monitor, and assess medical conditions, diseases, and infections in a controlled environment. These tests help in early diagnosis of diseases by enhancing control on test procedures and provide accurate results, leading to quality treatment and shorter hospital stays. They are also minimally invasive and help in lowering treatment costs. Manufacturers develop reagents, analytical instruments such as automated analyzers, and accessory products including software to measure the quality and parameters of samples.
Technavio’s analysts forecast the IVD market in Europe to grow at a CAGR of 4.78% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the IVD market in Europe for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of IVD consumables and instruments in EU27 countries.
The market is divided into the following segments based on geography:
• Germany
• France
• UK
• Italy
• Spain
• Benelux
• Nordic
Technavio's report, IVD Market in Europe 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott Laboratories
• Beckman Coulter, Inc
• Becton, Dickinson and Company
• F. Hoffmann-La Roche Ltd
• Siemens Healthcare GmbH
• Thermo Fisher Scientific Inc
Other prominent vendors
• Abaxis
• A. Menarini Diagnostics
• Acon Laboratories
• Bio-Rad Laboratories
• Cepheid
• Chembio Diagnostic Systems
• Clarity Diagnostics
• DiagCor
• Helena Laboratories
• Hologic
• i-Sens
• Landwind Medical
• Mindray
• Nipro Diagnostics
• Randox Laboratories
• Snibe Diagnostics
• Span Diagnostics
• Sysmex
• Trivitron Healthcare
• URIT
Market driver
• High prevalence of chronic diseases and infections
• For a full, detailed list, view our report
Market challenge
• Competition among vendors and SMEs
• For a full, detailed list, view our report
Market trend
• Use of DNA probe-based diagnostics
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by application
• POCT devices market in Europe
• Immunodiagnostics market in Europe
• Blood glucose monitoring devices market in Europe
• Molecular diagnostics market in Europe
• Hematology devices market in Europe
• Microbiology devices market in Europe
• Tissue diagnostics market in Europe
• Coagulation testing devices market in Europe
PART 07: Geographical segmentation
• IVD market in Germany
• IVD market in France
• IVD market in UK
• IVD market in Italy
• IVD market in Spain
• IVD market in Benelux
• IVD market in Nordic countries
PART 08: Market drivers
• High prevalence of chronic diseases and infections
• Focus on early diagnosis and prevention
• Rise in public awareness
PART 09: Impact of drivers
PART 10: Market challenges
• Competition among vendors and SMEs
• Reimbursement and pricing structure
• Lack of skill in using POC IVD devices
• Limitations of POCT technology
PART 11: Impact of drivers and challenges
PART 12: Market trends
• Focus on real-time and digitalized treatment
• Use of DNA probe-based diagnostics
• Increase in M&A
PART 13: Vendor landscape
• Competitive scenario
• Abbott Diagnostics
• Beckman Coulter
• Becton, Dickinson
• Roche Diagnostics
• Siemens Healthcare
• Thermo Fisher Scientific
• Other prominent vendors
PART 14: Appendix
• List of abbreviations
PART 15: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: IVD market in Europe 2015-2020 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Segmentation of IVD market in Europe by application 2015
Exhibit 05: POCT devices market in Europe 2015-2020 ($ billions)
Exhibit 06: Immunodiagnostics market in Europe 2015-2020 ($ billions)
Exhibit 07: Blood glucose monitoring devices market in Europe 2015-2020 ($ billions)
Exhibit 08: Molecular diagnostic market in Europe 2015-2020 ($ billions)
Exhibit 09: Hematology devices market in Europe 2015-2020 ($ billions)
Exhibit 10: Microbiology devices market in Europe 2015-2020 ($ millions)
Exhibit 11: Tissue diagnostics market in Europe 2015-2020 ($ millions)
Exhibit 12: Coagulation testing devices market in Europe 2015-2020 ($ millions)
Exhibit 13: Segmentation of IVD market in Europe by geography 2015
Exhibit 14: IVD market in Germany 2015-2020 ($ billions)
Exhibit 15: IVD market in France 2015-2020 ($ billions)
Exhibit 16: IVD market in UK 2015-2020 ($ billions)
Exhibit 17: IVD market in Italy 2015-2020 ($ billions)
Exhibit 18: IVD market in Spain 2015-2020 ($ billions)
Exhibit 19: IVD market in Benelux 2015-2020 ($ millions)
Exhibit 20: IVD market in Nordic countries 2015-2020 ($ billions)
Exhibit 21: Impact of drivers
Exhibit 22: Impact of drivers and challenges
Exhibit 23: Abbott Diagnostics: Key takeaways
Exhibit 24: Product offerings
Exhibit 25: Beckman Coulter: Key takeaways
Exhibit 26: Product offerings
Exhibit 27: Becton, Dickinson: Key takeaways
Exhibit 28: Roche Diagnostics: Business segmentation by revenue 2014
Exhibit 29: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 (billions)
Exhibit 30: Roche Diagnostics: Geographical segmentation by revenue 2014
Exhibit 31: Roche Diagnostics: Geographical segmentation by revenue 2013 and 2014 (billions)
Exhibit 32: Roche Diagnostics: Segmentation by revenue in EMEA 2014
Exhibit 33: Roche Diagnostics: Key takeaways
Exhibit 34: Siemens Healthcare: Key takeaways
Exhibit 35: Thermo Fisher Scientific: Geographical segmentation by revenue 2014
Exhibit 36: Thermo Fisher Scientific: Key takeaways
